Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7758855

DNA promoters and anthrax vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759106

Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754227

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7744902

Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7736656

Immunogenic compositions and vaccines for Ebola

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7731939

Vaccine compositions and adjuvant

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709007

Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide seque

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709257

Models for vaccine assessment

VaxDesign Corp. · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7709190

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704510

Cytomegalovirus surface protein complex for use in vaccines and as a drug target

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7682618

Generation of virus-like particles and use as panfilovirus vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666404

Glanders/meliodosis vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666427

HIV vaccines based on Env of multiple clades of HIV

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662397

Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655247

Malaria vaccines

The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638130

Truncated recombinant major outer membrane protein antigen (R56) of Orientia tsutsugamushi

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638333

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635483

Streptococcal C5a peptidase vaccine

Regents of the University of Minnesota · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635688

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632508

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7625571

Transformed bacteria producing CS6 antigens as vaccines

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622123

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608268

Ferritin fusion proteins for use in vaccines and other applications

New Century Pharmaceuticals, Inc. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7604811

Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens

The United States of America as represented by the Secretary of the Army · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted